Francis D A, Compston D A, Batchelor J R, McDonald W I
J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):758-65. doi: 10.1136/jnnp.50.6.758.
One hundred and one of 146 patients presenting with isolated idiopathic optic neuritis, previously reviewed in 1978, were reassessed clinically, and retyped for HLA antigens and Factor B alleles, after a mean follow-up of 11.6 years. Fifty eight patients (57%) had developed multiple sclerosis at the time of reassessment in the present study, of whom 51 (88%) had clinically definite disease. This compared with 40% of the original group, in 1978, of whom 62% then had clinically definite multiple sclerosis. When the life-table method of analysis was used, the probability of developing multiple sclerosis was 75%, 15 years after the initial episode of optic neuritis. The frequencies of HLA-DR2 and the recently defined D-region antigen, DQw1, were significantly increased in patients with isolated optic neuritis and those who subsequently developed multiple sclerosis compared with normal controls, but neither allele appears to influence progression from optic neuritis to multiple sclerosis. Patients with optic neuritis who were HLA-DR3 positive had an increased risk for the development of multiple sclerosis (RR = 2.8) and this risk was further enhanced when DR3 occurred in combination with DR2 (RR = 6.7). The overall increased risk of developing multiple sclerosis for patients with this combination was 26 times that for the normal population. When the patients' original tissue-typing was considered BT 101 no longer influenced conversion of optic neuritis to multiple sclerosis. This may partly be explained by improved methods of tissue-typing, since not all BT 101 patients were subsequently found to be positive for HLA-DR2 or HLA-DQw1 and vice versa and by extended follow-up as multiple sclerosis conversion in HLA-DR2 negative individuals increased with time. All 101 patients were typed for Factor B alleles. No significant differences in frequencies were found between individuals with isolated optic neuritis or those who progressed to multiple sclerosis compared with the control population. Recurrent episodes of optic neuritis were associated with an increased risk for the development of multiple sclerosis in this study.
1978年曾接受过评估的146例单纯性特发性视神经炎患者中的101例,在平均随访11.6年后,再次进行了临床评估,并重新进行了HLA抗原和B因子等位基因分型。在本研究重新评估时,58例患者(57%)已发生多发性硬化,其中51例(88%)有临床确诊疾病。这与1978年原组的40%相比,当时原组62%有临床确诊的多发性硬化。采用寿命表分析法时,视神经炎初次发作15年后发生多发性硬化的概率为75%。与正常对照相比,单纯性视神经炎患者以及随后发生多发性硬化的患者中,HLA-DR2和最近定义的D区抗原DQw1的频率显著增加,但这两个等位基因似乎均不影响从视神经炎进展为多发性硬化。HLA-DR3阳性的视神经炎患者发生多发性硬化的风险增加(相对危险度=2.8),当DR3与DR2同时出现时,这一风险进一步增加(相对危险度=6.7)。具有这种组合的患者发生多发性硬化的总体风险增加是正常人群的26倍。当考虑患者最初的组织分型时,BT 101不再影响视神经炎向多发性硬化的转化。这可能部分是由于组织分型方法的改进,因为并非所有BT 101患者随后都被发现HLA-DR2或HLA-DQw1呈阳性,反之亦然,还由于随访时间延长,因为HLA-DR2阴性个体中多发性硬化的转化随时间增加。对所有101例患者进行了B因子等位基因分型。与对照人群相比,单纯性视神经炎患者或进展为多发性硬化的患者在频率上未发现显著差异。在本研究中,复发性视神经炎发作与发生多发性硬化的风险增加相关。